New drug SUL-238 aims to boost brain energy in Parkinson's patients
Symptom relief
Recruiting now
This study tests a new drug called SUL-238 in people with early, untreated Parkinson's disease. The goal is to see if the drug improves how brain cells produce energy, measured with a special MRI scan. Participants will take the drug or a placebo daily for 28 days and have regula…
Phase: PHASE2 • Sponsor: GEN İlaç ve Sağlık Ürünleri A.Ş. • Aim: Symptom relief
Last updated Apr 29, 2026 15:04 UTC